T. Rowe Price Investment Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.52M | Sell |
|
|||||
|
2025
Q2 | $20.6M | Buy |
|
|||||
|
2025
Q1 | $23.1M | Sell |
|
|||||
|
2024
Q4 | $51.3M | Sell |
|
|||||
|
2024
Q3 | $54.6M | Sell |
|
|||||
|
2024
Q2 | $60.3M | Sell |
|
|||||
|
2024
Q1 | $124M | Buy |
|
|||||
|
2023
Q4 | $86M | Buy |
|
|||||
|
2023
Q3 | $48.8M | Buy |
|
|||||
|
2023
Q2 | $17.4M | Buy |
|
|||||
|
2023
Q1 | $14.9M | Buy |
|